Stephen B Heitner

Title: Innovations by Stephen B. Heitner in Cardiac Treatment

Introduction

Stephen B. Heitner is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of cardiology, particularly in the treatment of hypertrophic cardiomyopathy. His innovative approaches have the potential to improve patient outcomes and advance medical practices.

Latest Patents

Stephen B. Heitner holds a patent for "Methods for treating hypertrophic cardiomyopathy." This patent describes methods for treating obstructive hypertrophic cardiomyopathy through the administration of a cardiac myosin inhibitor, specifically CK-3773274, also known as CK-274 or aficamten. The treatment methods include titrating the daily dose based on various components of an echocardiogram. The daily dose may be adjusted—whether increased, maintained, decreased, or terminated—based on the echocardiogram results.

Career Highlights

Heitner is associated with Cytokinetics, Inc., where he continues to work on innovative solutions in cardiac treatment. His expertise and dedication to research have positioned him as a key figure in the development of new therapies for heart conditions.

Collaborations

Some of his notable coworkers include Fady Malik and Stuart Kupfer. Their collaborative efforts contribute to the advancement of research and development in the field of cardiology.

Conclusion

Stephen B. Heitner's work in developing methods for treating hypertrophic cardiomyopathy showcases his commitment to improving cardiac health. His innovative approaches and collaborations with other professionals highlight the importance of teamwork in advancing medical science.